AllCardiovascular MetabolismGene & Cell TherapyGT/CTIn VivoInfectious DiseaseMalariaMetabolic DiseaseNAFLD / NASHRegenerativeViral HepatitisYecuris Services AAV-HBV ModelGene & Cell Therapy, GT/CT, In Vivo, Infectious Disease, Viral HepatitisFRGN mice repopulated with a hemophilia B donorGene & Cell Therapy, GT/CT, In VivoGalNac-siRNA knowndown of human C5 in liver-humanized miceGene & Cell Therapy, GT/CT, In VivoCholesterol lipoprotein metabolism & LXR-agonist PD in humanized FRG miceCardiovascular Metabolism, NAFLD / NASHNovel HCV Antiviral Screening in FRG MiceViral HepatitisHEV Infection in FRG Mice from Patient PlasmaViral HepatitisEfficacy of Ribonuclease H Inhibitors for HBV Infection in FRG MiceViral HepatitisRecapitulation of Treatment Response to HBV Infection in FRG MiceViral HepatitisFRG Mice for HBV and HCV ModelingViral HepatitisPlasmodium Berghei Vaccination Platform in FRG MiceMalariaPlasmodium Falciparum In Vivo Liver to Blood Stage in FRG MiceMalariaMonoclonal Antibody Blocking of Malaria in FRG MiceMalariaHuman to Mouse Antibody Transfer in FRG MiceMalariaIn Vivo Drug Efficacy Against Plasmodium FalciparumMalariaPlasmodium Falciparum Genetic Crosses in FRG MiceMalariaAlirocumab Response in FRG MiceCardiovascular Metabolism, NAFLD / NASHHumanized Mouse Lipoprotein ProfilingNAFLD / NASH, RegenerativeCorrection of Familial HypercholesterolaemiaGT/CT, Metabolic Disease, NAFLD / NASHIn Vivo AAV SelectionGT/CTAAV Gene Repair of HT1GT/CT, Metabolic DiseaseRNAi Prevents HBV SelectionGT/CT, Infectious Disease, Viral HepatitisEx Vivo Correction of HT1GT/CT, Metabolic DiseaseIn VivoGene & Cell TherapyEx VivoGene & Cell Therapy
